Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05551403Not ApplicableCompleted

Cortical Excitability and Treatment Response in People with Epilepsy

Role: lead

NCT04617418Unknown

Smartphone Behavior and Epilepsy Management

Role: lead

NCT03909984Not ApplicableCompleted

Promoting Implementation of Seizure Detection Devices in Epilepsy Care

Role: lead

NCT02415686Completed

Cardiac Arrhythmias in Dravet Syndrome

Role: lead

NCT01946776Not ApplicableCompleted

Cardiac Arrhythmias in Epilepsy: the CARELINK-study

Role: lead

All 5 trials loaded